vs
Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $17.3M, roughly 1.4× ROCKWELL MEDICAL, INC.). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -9.2%, a 23.8% gap on every dollar of revenue. On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-8.5% vs -25.0%). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-18.2% CAGR vs -23.9%).
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
GENC vs RMTI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $17.3M |
| Net Profit | $3.4M | $-1.6M |
| Gross Margin | 28.7% | 16.8% |
| Operating Margin | 13.2% | — |
| Net Margin | 14.6% | -9.2% |
| Revenue YoY | -25.0% | -8.5% |
| Net Profit YoY | -9.8% | — |
| EPS (diluted) | $0.23 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $17.3M | ||
| Q4 25 | $23.6M | $18.3M | ||
| Q3 25 | $18.8M | $15.9M | ||
| Q2 25 | $27.0M | $16.1M | ||
| Q1 25 | $38.2M | $18.9M | ||
| Q4 24 | $31.4M | $24.7M | ||
| Q3 24 | $20.9M | $28.3M | ||
| Q2 24 | $25.6M | $25.8M |
| Q1 26 | — | $-1.6M | ||
| Q4 25 | $3.4M | $-554.0K | ||
| Q3 25 | $1.9M | $-1.8M | ||
| Q2 25 | $3.8M | $-1.5M | ||
| Q1 25 | $6.1M | $-1.5M | ||
| Q4 24 | $3.8M | $-756.0K | ||
| Q3 24 | $1.5M | $1.7M | ||
| Q2 24 | $2.6M | $343.0K |
| Q1 26 | — | 16.8% | ||
| Q4 25 | 28.7% | 21.1% | ||
| Q3 25 | 24.2% | 14.3% | ||
| Q2 25 | 26.5% | 15.6% | ||
| Q1 25 | 29.7% | 16.1% | ||
| Q4 24 | 27.6% | 14.7% | ||
| Q3 24 | 25.6% | 22.0% | ||
| Q2 24 | 23.9% | 17.6% |
| Q1 26 | — | — | ||
| Q4 25 | 13.2% | -2.2% | ||
| Q3 25 | -1.2% | -9.9% | ||
| Q2 25 | 11.6% | -8.4% | ||
| Q1 25 | 17.0% | -7.2% | ||
| Q4 24 | 14.7% | -2.1% | ||
| Q3 24 | 5.9% | 6.8% | ||
| Q2 24 | 7.8% | 2.0% |
| Q1 26 | — | -9.2% | ||
| Q4 25 | 14.6% | -3.0% | ||
| Q3 25 | 10.2% | -11.0% | ||
| Q2 25 | 14.2% | -9.3% | ||
| Q1 25 | 16.0% | -8.0% | ||
| Q4 24 | 12.1% | -3.1% | ||
| Q3 24 | 6.9% | 5.9% | ||
| Q2 24 | 10.0% | 1.3% |
| Q1 26 | — | $-0.04 | ||
| Q4 25 | $0.23 | $-0.01 | ||
| Q3 25 | $0.13 | $-0.05 | ||
| Q2 25 | $0.26 | $-0.05 | ||
| Q1 25 | $0.42 | $-0.04 | ||
| Q4 24 | $0.26 | $-0.02 | ||
| Q3 24 | $0.10 | $0.04 | ||
| Q2 24 | $0.17 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $215.2M | $35.9M |
| Total Assets | $228.9M | $57.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $147.7M | $10.7M | ||
| Q3 25 | $136.3M | $13.6M | ||
| Q2 25 | $136.0M | $12.5M | ||
| Q1 25 | $143.7M | $11.4M | ||
| Q4 24 | $130.1M | $15.7M | ||
| Q3 24 | $115.4M | $12.3M | ||
| Q2 24 | $116.6M | $11.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $35.9M | ||
| Q4 25 | $215.2M | $37.0M | ||
| Q3 25 | $211.8M | $37.0M | ||
| Q2 25 | $209.9M | $30.4M | ||
| Q1 25 | $206.1M | $31.5M | ||
| Q4 24 | $200.0M | $32.6M | ||
| Q3 24 | $196.1M | $29.1M | ||
| Q2 24 | $194.7M | $23.5M |
| Q1 26 | — | $57.4M | ||
| Q4 25 | $228.9M | $57.1M | ||
| Q3 25 | $222.6M | $57.5M | ||
| Q2 25 | $220.2M | $52.6M | ||
| Q1 25 | $223.9M | $54.0M | ||
| Q4 24 | $218.2M | $59.2M | ||
| Q3 24 | $208.1M | $57.1M | ||
| Q2 24 | $201.8M | $53.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.1M | — |
| Free Cash FlowOCF − Capex | $10.1M | — |
| FCF MarginFCF / Revenue | 43.0% | — |
| Capex IntensityCapex / Revenue | 4.1% | — |
| Cash ConversionOCF / Net Profit | 3.23× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | $2.3M | ||
| Q3 25 | $-275.0K | $-1.3M | ||
| Q2 25 | $-23.9M | $1.8M | ||
| Q1 25 | $12.4M | $-3.5M | ||
| Q4 24 | $14.8M | $865.0K | ||
| Q3 24 | $-3.2M | $4.3M | ||
| Q2 24 | $-1.0M | $1.4M |
| Q1 26 | — | — | ||
| Q4 25 | $10.1M | $2.2M | ||
| Q3 25 | $-1.3M | $-1.5M | ||
| Q2 25 | $-24.4M | $1.7M | ||
| Q1 25 | $12.3M | $-3.5M | ||
| Q4 24 | $14.5M | $470.0K | ||
| Q3 24 | $-3.3M | $4.1M | ||
| Q2 24 | $-1.4M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 43.0% | 12.0% | ||
| Q3 25 | -6.8% | -9.6% | ||
| Q2 25 | -90.4% | 10.5% | ||
| Q1 25 | 32.2% | -18.8% | ||
| Q4 24 | 46.1% | 1.9% | ||
| Q3 24 | -15.8% | 14.4% | ||
| Q2 24 | -5.6% | 4.5% |
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 0.5% | ||
| Q3 25 | 5.4% | 1.4% | ||
| Q2 25 | 1.8% | 1.0% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 1.0% | 1.6% | ||
| Q3 24 | 0.4% | 0.7% | ||
| Q2 24 | 1.5% | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | 3.23× | — | ||
| Q3 25 | -0.14× | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | 2.04× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | -2.22× | 2.57× | ||
| Q2 24 | -0.41× | 4.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
